Abstract:Objective: In a rat model, we studied the time courses of vascular endothelial growth factor (VEGF) expression and angiogenesis induced by chronic cerebral hypoperfusion in the brain, and we investigated the histological basis of normal-perfusion pressure breakthrough. Methods: Twenty-one Sprague-Dawley rats were randomly divided into a control group (n = 3) and a model group assessed at various time points after the creation of a carotid artery-jugular vein fistula (12 h, n = 3; 24 h, n = 3; 72 h, n = 3; 7 d, n = 3; 21 d, n = 3; 90 d, n = 3). The time courses of the expression of VEGF messenger ribonucleic acid (mRNA) and protein in rat brain were analyzed with semiquantitative reverse transcriptase-polymerase chain reaction and Western blot assays, respectively. Immunohistochemical techniques were used to evaluate VEGF protein localization with rabbit polyclonal anti-rat VEGF, VEGF receptor (VEGFR) expression with rabbit polyclonal antibodies to VEGFR-1 and -2, microvascular density with mouse monoclonal anti-rat CD31, and astrocytic reactivity with polyclonal anti-glial fibrillary acidic protein, in cerebral cortical tissue of the right middle cerebral artery territory. Results: Three alternative splicing forms, i.e., VEGF(188), VEGF(164), and VEGF(120), were observed in cerebral cortical tissue of the right middle cerebral artery territory in semiquantitative reverse transcriptase-polymerase chain reaction analyses. VEGF(164) mRNA was the predominant isoform expressed in rat brain. VEGF(188) mRNA and VEGF(120) mRNA were also detected but at very low levels (not statistically significant). Low levels of VEGF(164) mRNA were observed in the control brains. However, VEGF(164) mRNA levels were significantly increased in the model brains at 24 hours postoperatively, peaked by 7 days, decreased by 21 days, and returned to basal levels by 90 days after fistula formation. VEGF protein expression, as measured in Western blot assays, was also increased in rat brains in the model group from 24 hours to 21 days postoperatively but returned to control levels by 90 days after fistula formation. VEGF immunohistochemical analyses indicated that this increased expression was mostly associated with endothelial cells. Consistent with the VEGF protein expression findings, up-regulation of VEGFR-1 but not VEGFR-2 expression on endothelial cells in the model brains was observed. Microvascular density in the rat brains began to increase significantly 7 days after fistula formation in the model group, as assessed immunohistochemically, and the increase was maintained for 90 days. Although no prominent astrocytic reactivity was observed in the rat brains throughout the experiments, there was an absence of astrocytic foot processes surrounding some cerebral capillaries 90 days after fistula formation in the model group. Conclusion: These results demonstrated that chronic cerebral hypoperfusion could induce sustained up-regulation of VEGF mRNA and protein expression in rat brain, which was correlated with angiogenesis. An absence of corresponding astrocytic reactivity during angiogenesis may be an important factor accounting for structural deficits of the blood-brain barrier and the occurrence of normal-perfusion pressure breakthrough.

A Pivotal Role of the Vascular Endothelial Growth Factor Signaling Pathway in the Formation of Venous Hypertension-Induced Dural Arteriovenous Fistulas

Expression Of Hypoxia-Inducible Factor-1 And Vascular Endothelial Growth Factor In Response To Venous Hypertension

Endovascular Treatment for Dural Arteriovenous Fistulas in the Petroclival Region

Initial Etiological Research of Intracranial Dural Arteriovenous Fistulas

Investigation of the Mechanism of Dural Arteriovenous Fistula Formation Induced by High Intracranial Venous Pressure in a Rabbit Model

Local chronic hypoperfusion secondary to sinus high pressure seems to be mainly responsible for the formation of intracranial dural arteriovenous fistula.

Nonischemic Cerebral Venous Hypertension Promotes A Pro-Angiogenic Stage Through Hif-1 Downstream Genes And Leukocyte-Derived Mmp-9

Brain venous hypertension induces angiogenesis through overexpression of hypoxia-inducible factor-1 (HIF-1)

Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain

Dural arteriovenous fistula may be occluded through recanalization of impaired venous sinuses

Development of a dural arteriovenous fistula subsequent to cerebral venous thrombosis by venous hypertension

Preliminary Study on the Hemodynamics of Cognard Typeⅳdural Arteriovenous Fistulas with Venous Aneurysm

Pathology and Protein Changes of the Spinal Dural Arteriovenous Fistula Arterial Draining Vein under Sustained High Vascular Pressure

Dural arteriovenous fistulae at the craniocervical junction: the relation between clinical symptom and pattern of venous drainage.

The Role of SDF-1/CXCR4 in the Vasculogenesis and Remodeling of Cerebral Arteriovenous Malformation

Ipsilateral Intracranial Edema Associated with Drainage Patterns of Dural Arteriovenous Fistula.

The Transcriptional Landscapes and Key Genes in Brain Arteriovenous Malformation Progression in a Venous Hypertension Rat Model Revealed by RNA Sequencing

Postoperative Outcomes of Patients with Dural Arteriovenous Fistulas: an Analysis of Influencing Factorsof Influencing Factors

The Vascular Architecture of Cavernous Sinus Dural Arteriovenous Fistula and Its Impact on Endovascular Treatment Approach Selection and Outcome.

Sigmoid sinus dural arteriovenous fistuladiagnosis and treatment

VDR alleviates endothelial cell injury in arteriovenous fistula through inhibition of P66Shc-mediated mitochondrial ROS